A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice
Abstract Dengue viruses (DENV) cause an estimated 390 million infections globally. With no dengue-specific therapeutic treatment currently available, vaccination is the most promising strategy for its control. A wide range of DENV vaccines are in development, with one having already been licensed, a...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/3a288fab6e9c432db1197a1c7a39ffd8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|